Which super funds hold Swedish Orphan Biovitrum Ab (Publ)?

As at 31 December 2025, 12 Australian super investment options in our dataset held Swedish Orphan Biovitrum Ab (Publ), the largest weighting being 0.01% in Index Diversified (Accumulation) (AustralianSuper).

Options holding it

12

Largest weighting

0.01%

Index Diversified (Accumulation) · AustralianSuper

Funds & options holding Swedish Orphan Biovitrum Ab (Publ)

Australian super investment options disclosing a holding in Swedish Orphan Biovitrum Ab (Publ). Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.

FundPhaseOptionWeightingValue (AUD)As at
AustralianSuperAccumulationBalanced (Accumulation)
0.00%
$476,85331 December 2025
AustralianSuperAccumulationIndex Diversified (Accumulation)
0.01%
$269,59831 December 2025
AustralianSuperRetirementIndex Diversified (Income)
0.01%
$122,61231 December 2025
AustralianSuperAccumulationHigh Growth (Accumulation)
0.00%
$107,07331 December 2025
AustralianSuperRetirementBalanced (Income)
0.00%
$63,15131 December 2025
AustralianSuperAccumulationInternational Shares (Accumulation)
0.00%
$56,05531 December 2025
AustralianSuperRetirementConservative Balanced (Income)
0.00%
$13,09031 December 2025
AustralianSuperAccumulationConservative Balanced (Accumulation)
0.00%
$10,79731 December 2025
AustralianSuperRetirementInternational Shares (Income)
0.00%
$8,34831 December 2025
AustralianSuperRetirementHigh Growth (Income)
0.00%
$7,24631 December 2025
AustralianSuperAccumulationStable (Accumulation)
0.00%
$4,51631 December 2025
AustralianSuperRetirementStable (Income)
0.00%
$4,16031 December 2025

This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.

Methodology — how holdings are sourced, resolved and aggregated.

LookThrough shows the actual holdings inside Australian super funds, with cross-fund look-through.

  • 4 of 86 funds
  • 36 of 111 options reviewed
  • 7,010 of 7,168 securities reviewed

© 2026 LookThrough. Factual disclosure information — not financial advice, a rating or a recommendation.